The volume of sucrose given ranged from 0.2 to 0.75 mL and was based on the infant's weight. This rnethod of administration'rryas chosen to standardize the dose intensity among infants to 0.1 to 0.15 g/kg. Immediatelybefore andbetweert2arrd 5 minutes after the commencement of sucrose administration, blood samples (0.8-1.0 mL) were obtained using an indwelling arterial catheter to determine serum B-endorphin concentration. Infants were obsen'ed for adverse events during the adrninistration of sucrose, including choking, vomiting, apnea, or bradycardia. The infants did not undergo a painful procedure during the study period.
Infants rvere not eligible for the study if they had congenital anomalies, were clinically unstable, or were receiving opioid analgesics. The research ethics boards of both participating institutions approved the study protocol, and informed parental consent was obtained for all infans.
Blood 
